16–20 November 2026 | Dublin & Online
Registration is now open for the 4th edition of the PRECISEU Personalised Medicine School, hosted by NIBRT – the National Institute for Bioprocessing Research and Training in Ireland.
Taking place from 16 to 20 November 2026, this five-day programme will focus on one of the most important challenges in personalised medicine: how to move advanced therapy medicinal products (ATMPs) and RNA medicines from the laboratory to the patient.
Across a hybrid opening workshop and four days of online masterclasses, participants will explore how collaboration, clinical translation and next-generation biomanufacturing can work together to accelerate the development and access to advanced therapies across Europe.
From collaboration to clinical translation
The week will open on Monday, 16 November, with a hybrid workshop on Collaboration Models for ATMP Development, led by Dr Friedemann Loos, Innovation Manager at bioRN Life Science Cluster.
The programme will then continue online with experts from NIBRT, CONCEPT, Rinn Advanced Therapies, and Rinn Pharma and Biopharma, covering topics ranging from early-stage biotherapy development and manufacturing innovation to RNA medicine translation and glycobiology.
Preliminary programme at a glance
Monday, 16 November | Hybrid
Collaboration Models for ATMP Development
Dr Friedemann Loos, bioRN Life Science ClusterTuesday, 17 November | Online
CONCEPT: A Core Facility for Early-Stage Biotherapy Development
Dr Clair Gallagher, CONCEPTTrends in Biopharmaceuticals and their Manufacture – “Solutions in a rapidly changing landscape”
Dr John Milne, NIBRTWednesday, 18 November | Online
Masterclass with Prof Elena Matsa, NIBRT, University College Cork and Rinn Advanced TherapiesThursday, 19 November | Online
Research Insights into Clinical Translation of RNA Medicines
Prof Damien Thompson, Prof Steven Ferguson and Prof Piotr Kowalski, Rinn Pharma and BiopharmaFriday, 20 November | Online
Applications of Glycobiology: From Glycan Analysis to Glycoengineering
Prof Radka Fahey and Prof Michael Butler, NIBRT
Who should join?
The 4th PRECISEU PM School is designed for:
- researchers and clinicians;
- industry professionals;
- innovators and entrepreneurs;
- policymakers;
- stakeholders working across the European ATMP and personalised medicine ecosystem.
The programme combines expert perspectives with practical discussion and opportunities to connect across disciplines and regions.
Why this matters
Advanced therapies have enormous potential, but moving them successfully from scientific discovery to clinical application requires more than research excellence alone.
Manufacturing capability, translational expertise, regulatory pathways, collaboration between sectors and access to the right infrastructures all play a role.
Through the PRECISEU PM School, we aim to strengthen the knowledge, skills and connections needed to help European personalised medicine ecosystems move from innovation towards implementation and patient access.
Registration is open!
Join us from 16–20 November 2026 for five days of expert insight, practical perspectives and European collaboration around the future of advanced therapies.
👉 REGISTER NOW FOR PRECISEU PM SCHOOL 2026, 4th edition
https://us02web.zoom.us/meeting/register/-5RE6zdIQHWYXT6iayQWjQ
Participation details and online access information will be provided through the registration process.
The 4th PRECISEU PM School is hosted by NIBRT as part of PRECISEU’s ongoing work to strengthen capacity, knowledge exchange and collaboration across European personalised medicine ecosystems.